This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Should Everest Re (EG) Be in Your Kitty Before Q1 Earnings?
by Zacks Equity Research
Everest Re's (EG) first-quarter results are likely to benefit from diversified growth across most lines of business, an increase in property lines, higher new money yields and prudent underwriting.
Will Arch Capital (ACGL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Arch Capital (ACGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should Arch Capital (ACGL) Be in Your Kitty Before Q1 Earnings?
by Zacks Equity Research
Arch Capital's (ACGL) first-quarter results are likely to benefit from improved premiums, aided by better pricing and new business opportunities.
Unlocking Q1 Potential of Arch Capital (ACGL): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Arch Capital (ACGL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
RenaissanceRe (RNR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
RenaissanceRe (RNR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arch Capital Group (ACGL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arch Capital (ACGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons Why Investors Should Retain Arch Capital (ACGL)
by Zacks Equity Research
Arch Capital (ACGL) remains poised to gain from new business opportunities, rate increases, strategic acquisitions and a solid capital position.
Here's Why Investors Should Buy AXIS Capital (AXS) Stock Now
by Zacks Equity Research
AXIS Capital (AXS) remains well-poised to gain from higher net investment income, strong market presence, better pricing, solid balance sheet and effective capital deployment.
Arch Capital (ACGL) Unit to Expand in Middle-Market P&C Segment
by Zacks Equity Research
Arch Capital (ACGL) unit, Arch Insurance North America, sets sights on expansion, acquiring Allianz's U.S. MidCorp and Entertainment insurance businesses for $450 million cash.
Here's How Much You'd Have If You Invested $1000 in Arch Capital Group a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Is Credit Agricole (CRARY) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Credit Agricole SA (CRARY) and Arch Capital Group (ACGL) have performed compared to their sector so far this year.
All You Need to Know About Arch Capital (ACGL) Rating Upgrade to Buy
by Zacks Equity Research
Arch Capital (ACGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Ellington Residential Mortgage REIT (EARN) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Ellington Residential (EARN) and Arch Capital Group (ACGL) have performed compared to their sector so far this year.
If You Invested $1000 in Arch Capital Group a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Arch Capital (ACGL) Up 4.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Arch Capital (ACGL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Arch Capital (ACGL) Surges 23% YTD: More Room for Growth?
by Zacks Equity Research
Arch Capital (ACGL) continues to gain from business opportunities, rate increases, growth in existing accounts and a solid capital position.
Why Arch Capital (ACGL) Stock Might be a Great Pick
by Zacks Equity Research
Arch Capital (ACGL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Here's How Much a $1000 Investment in Arch Capital Group Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Top Stock Reports for Costco, Walt Disney & AstraZeneca
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), The Walt Disney Company (DIS) and AstraZeneca PLC (AZN).
Reasons to Retain American Financial (AFG) Stock for Now
by Zacks Equity Research
American Financial (AFG) is well-poised to gain from rate increases, a rise in average renewal pricing, stronger underwriting profit, improved guidance and effective capital deployment.
Here's Why Investors Should Hold Selective Insurance (SIGI)
by Zacks Equity Research
Selective Insurance (SIGI) stands to gain from strong renewal, fuel price increases, exposure growth, higher income earned on fixed-income securities portfolio and prudent capital deployment.
Here's Why AXIS Capital (AXS) is Investors' Favorite Now
by Zacks Equity Research
AXIS Capital (AXS) continues to build on Specialty Insurance, Reinsurance plus Accident and Health. Its improved portfolio mix and effective capital deployment should pave the way for growth.
Berkshire Hathaway (BRK.B) Q4 Earnings Rise Year Over Year
by Zacks Equity Research
Berkshire Hathaway's (BRK.B) Q4 results reflect higher insurance premiums earned, improved underwriting results at GEICO and a rise in freight rail transportation revenues.
Skyward Specialty Insurance Group, Inc. (SKWD) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AMERISAFE (AMSF) Beats Q4 Earnings, Hikes Dividend by 8.8%
by Zacks Equity Research
AMERISAFE's (AMSF) fourth-quarter results benefit from improved net premiums written and increased fixed income reinvestment rates, partly offset by a rise in underwriting and other operating costs.